The guiding principles behind the financial exercise that some view as an art form.
This is a preview of subscription content
Access options
Subscribe to Journal
Get full journal access for 1 year
114,72 €
only 9,56 € per issue
Tax calculation will be finalised during checkout.
Buy article
Get time limited or full article access on ReadCube.
$32.00
All prices are NET prices.
References
The authors state that the descriptions and views given in the present article are their own personal views and descriptions and do not represent the formal opinions and positions of their employers. No warranties are given or made, and anyone wishing to apply the methods above should consult professional advisors.
Copeland, T. and Koller, T. Murrin, J. 1996. Measuring and managing the value of companies. Second Edition. John Wiley & Sons, Inc. NY.
Fusfeld, A.R. 1996. Placing a value on R&D. CHEMTECH 26(5): 46–50.
Struck, M.M. 1994. Biopharmaceutical R&D success: Rates and. development times. Bio/Technology 12: 674–677.
Bernstein, K. 1997. Is first best?. BioCentury 5(45): A1–A6.
Persidis, A. 1997. Industry Trends: Combinatorial chemistry. Nature Biotechnology 15: 479–480.
Author information
Affiliations
Rights and permissions
About this article
Cite this article
Persidis, A., Menzel, G. Biotechnology valuation. Nat Biotechnol 15, 813–814 (1997). https://doi.org/10.1038/nbt0897-813
Issue Date:
DOI: https://doi.org/10.1038/nbt0897-813
Further reading
-
Value drivers in licensing deals
Nature Biotechnology (2002)